BeiGene Ltd. (BGNE) Surged To A New High After Celgene Collaboration

BeiGene Ltd. (BGNE) announced Thursday morning that it has entered into a strategic collaboration with Celgene (CELG) to advance its cell death protein 1 inhibitor, BGB-A317 for patients with solid tumor cancers.

from RTT - Before the Bell http://ift.tt/2too59N
via IFTTT